Tuesday

24th Jan 2017

EU fines pharma-giants €427mn in ‘pay for delay’ case

  • French pharma-giant Servier was among a string of firms fined over €400 million in the EU's largest 'pay for delay' case. (Photo: Grumpy-Puddin)

French pharmaceutical firm Servier will bear the brunt of a €427 million anti-trust fine in the largest ‘pay for delay’ case brought by the European Commission.

Speaking at a news conference on Wednesday (9 July), EU competition commissioner Joaquin Almunia said Servier was guilty of protecting its bestselling blood pressure drug, perindopril, from price competition by generics in the EU between 2005 and 2007.

Dear EUobserver reader

Subscribe now for unrestricted access to EUobserver.

Sign up for 30 days' free trial, no obligation. Full subscription only 15 € / month or 150 € / year.

  1. Unlimited access on desktop and mobile
  2. All premium articles, analysis, commentary and investigations
  3. EUobserver archives

EUobserver is the only independent news media covering EU affairs in Brussels and all 28 member states.

♡ We value your support.

If you already have an account click here to login.

Perindopril generated more than $1 billion per year in sales for Servier, revenues which the company feared it would lose when its patent control over the drug’s molecule expired. Servier then bought the technology needed to develop an alternative version and made a series of patent settlements with companies trying to produce generic forms of the drug.

Servier now faces a €330 million fine, while Niche/Unichem, Matrix Teva, Krka and Lupin - all producers of generic medicines - face fines totalling €97 million.

Internal documents of one generic company acknowledged that it was being "bought out of perindopril," while another insisted that any settlement with Servier would have to be for a "pile of cash".

Describing the behaviour as a “serious breach” of the bloc’s competition rules, Almunia added that “’pay for delay’ is clearly not acceptable”.

For its part, Servier’s spokesperson Lucy Vincent described the ruling as “a bad sign” and indicated that the company plans to appeal. Servier had “acted in a transparent and legitimate way to defend its patents,” she said.

The case is the largest "pay for delay" case brought by the EU executive, where a company has paid off rival firms to prevent them producing cheaper generic versions of a drug.

Pharmaceutical firms use a variety of means including secondary patents and ‘pay for delay’ settlements to prevent rivals from producing generic version of their drugs at a fraction of the price.

But anti-trust regulators in the US and the EU are now investigating a series of similar cases.

Last November, the Commission fined Johnson & Johnson, Novartis, and Lundbeck for paying off their rivals in the EU’s first ‘pay for delay’ cases.

“A company tried hard to unduly prolong its exclusively … not thanks to its innovation and the strength of its patents but thanks to its deep pockets and the complicity of its rivals,” commented Almunia.

“Pharmaceuticals companies should focus their efforts on innovating rather than trying to extract extra rents for patients and taxpayers,” he added.

Serbia-Kosovo talks back on track

After a series of setbacks that almost led to armed confrontation, Serbia and Kosovo are back at the negotiating table with a summit in Brussels.

News in Brief

  1. Greek island mayors plead for the transfer of migrants
  2. Tzipi Livni cancels Brussels trip amid war crimes probe
  3. Romania's president plans referendum on prisoner pardons
  4. Sweden to host EU social summit
  5. US Congress may Trump-proof Russia sanctions
  6. Fury over UK 'cover up' of failed missile test
  7. Theresa May: I will not be afraid to stand up to Trump
  8. Brexit will destroy NI peace deal, says Gerry Adams

Stakeholders' Highlights

  1. Dialogue PlatformThe Influence of Turkish Politics in Europe After the Coup Attempt
  2. World VisionEU Urged to do Better Ahead of Helsinki Conference on Syria
  3. Caritas EuropaEU States to Join Pope Francis’s Appeal to Care for Migrant Children
  4. UNICEFNumber of Unaccompanied Children Arriving by sea to Italy Doubles in 2016
  5. Nordic Council of Ministers"Nordic Matters" Help Forge Closer Bonds Between the UK and the Nordic Region
  6. Computers, Privacy & Data ProtectionThe age of Intelligent Machines: join the Conference on 25-27 January 2017
  7. Martens CentreNo Better way to Lift Your Monday Blues Than to Gloss Over our Political Cartoons
  8. Dialogue PlatformThe Gulen Movement: An Islamic Response to Terror as a Global Challenge
  9. European Free AllianceMinority Rights and Autonomy are a European Normality
  10. Swedish EnterprisesHow to Create EU Competitiveness Post-Brexit? Seminar on January 24th
  11. European Jewish CongressSchulz to be Awarded the European Medal for Tolerance for his Stand Against Populism
  12. Nordic Council of Ministers"Adventures in Moominland" Kick Off Nordic Matters Festival in London